01 Procurement
Tender overview
- Buyer
- MHRA
- Status
- Complete
- Procurement method
- Below threshold - without competition
- Category
- Not supplied
- CPV classification
- Not supplied
- Tender period
- Not supplied — Not supplied
Description
The Medicines and Healthcare Products Regulatory Agency is procuring a consultancy service to deliver the following 4 workstreams for the Fees Review and Uplift project: 1. Benchmarking, value proposition and performance guarantees. 2. SME and voucher scheme design 3. External challenge and quality assurance of the MHRA internal model 4. Price elasticity and market response. The project is reviewing, re-valuing and uplifting MHRA fees to cover the costs of capacity strengthening to provide improved services to industry. The project feeds into the draft MHRA 2030 strategy.
This page represents one OCDS contracting process. Notices can be revised over time. Values may be estimates, award values or contract values and should be read with their displayed stage and date.
02 Awards and contracts
Published award records
Fees Review and Uplift Consultancy for the MHRA
- Awarded
- Not supplied
- Award value
- Not supplied
- Suppliers
- 1
- Signed contract
- 19 March 2026
03 Organisations
Buyers, suppliers and other parties
MHRA
10 South Colonnade, Canary Wharf, London, UKI42, E14 4PU, United Kingdom
GB-PPON PJLJ-9824-VXPGCarnall Farrar Ltd
1 Lyric Square, London, UKI33, W6 0NB, United Kingdom
Companies House links appear only for explicit GB-COH identifiers. BritDB does not create company links from a similar name or address.
04 Provenance
Source for this process
Contains public sector information licensed under the Open Government Licence v3.0. Official external links are available only on the source transition page.